Holen Sie sich die Stockscreener-App
2.88
5.05%
0.11
Equillium Inc Aktie (EQ) Neueste Nachrichten
Equillium(EQ) Stock Options Chain | Quotes & News - Moomoo
EQ News | EQUILLIUM INC (NASDAQ:EQ) - ChartMill
Equillium (EQ) Gets a Buy from Oppenheimer - The Globe and Mail
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Equillium stock rating reaffirmed by Oppenheimer on rival drug data - Investing.com Canada
Equillium, Inc.(NasdaqCM: EQ) added to Russell 3000E Growth Benchmark - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell 3000E Index - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell Microcap Index - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Equillium Inc. (EQ) Q1 2026 Earnings: EPS Misses Estimates, Stock Gains 3.39% Amid Strategic Progress - dars.gov.et
Price to book forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Price to sales forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Equillium, Inc. Actuals & Estimates (NASDAQ:EQ) - TradingView
EQ Forecast — Price Target — Prediction for 2027 - TradingView
EQ Q1 2026 Earnings: EPS Miss Amid Pipeline Progress; Stock Rises 3%Special Dividend Alert - dars.gov.et
ETFs Investing in Equillium, Inc. Stocks - TradingView
Equillium Inc (EQ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
EQUILLIUM INC (EQ) Stock Chart - ChartMill
23% Of This Equillium Insider's Holdings Were Sold - simplywall.st
Equillium Inc (EQ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Equillium Inc (EQ) Institutional Confidence - TradingKey
Equillium Inc (EQ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Equillium Inc (EQ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equillium Inc (EQ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Equillium Inc (EQ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Equillium Inc (EQ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Equillium Inc (EQ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Equillium Inc. (EQ) Jumps 8.7%: Volume Surge and Key Resistance AheadNarrow Range Breakout - dars.gov.et
Equillium Inc. (EQ) Holds Steady at $2.81 – Key Support and Resistance Levels in FocusSystematic Flow - newsline.com
Equillium’s Lead Asset EQ504 Sees Growing Analyst Confidence Amid Pipeline ProgressDividend Cut Risk - newsline.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Insider Monkey
EQ Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
Equillium COO Christine Zedelmayer sells $42,736 in stock - Investing.com UK
Insider Sell: Stephen Connelly Sells 230,975 Shares of Equillium Inc (EQ) - GuruFocus
Equillium COO Christine Zedelmayer sells $42,736 in stock By Investing.com - Investing.com Nigeria
Equillium (NASDAQ: EQ) Form 144: insider resale activity, 200,000-share sale noted - Stock Titan
Equillium Insider Sold Shares Worth $723,830, According to a Recent SEC Filing - marketscreener.com
Equillium (EQ) COO sells 14,584 shares after exercising stock options - Stock Titan
Equillium (NASDAQ: EQ) CSO Stephen Connelly sells 230,975 shares in open market - Stock Titan
[144] Equillium, Inc. SEC Filing - Stock Titan
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory DiseaseSlideshow (NASDAQ:EQ) 2026-06-03 - Seeking Alpha
Equillium Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
B. Riley Securities Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Equillium links AhR activation to miR-124 as EQ504 heads toward Phase 1 - MSN
Is Equillium's AhR/miR-124 Axis the Key to Unlocking Inflammatory Disease Treatment - Kavout
Equillium Insider Sold Shares Worth $267,209, According to a Recent SEC Filing - Moomoo
Leerink Partners upgrades Equillium (EQ) - MSN
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares - Investing.com Australia
Equillium principal accounting officer Tom Penny sells $191,750 in stock By Investing.com - Investing.com Nigeria
1.95%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):